UK biotech Exscientia has terminated the employment of its founder and chief executive, Dr Andrew Hopkins, effective immediately, over what is described as “inappropriate relationship
The month of January saw a smattering of investor and agency hires, as well as a couple of non-profit and professional organisation hires that we’re throwing in for completeness’ sake.
It’s honestly getting harder to separate AI-powered pharma companies from pharma-focused AI companies as AI becomes more and more embedded in biopharma operations.
Japan’s Astellas has named Nick Eshkenazi to the new role of chief digital and transformation officer (CTDO), the first time it has included a digital role in its top mana
BenevolentAI’s search for a new chief executive has concluded with the appointment of industry bigwig Dr Jörg Möller to the role, four months after Joanna Shields stepped